TrialAnnals of the rheumatic diseases2014
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.
R Landewé et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
215 papers cite itlatest 60 shown
this paperpooled ittrialcites it